vs
Ecovyst Inc.（ECVT）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是Ecovyst Inc.的1.6倍（$311.4M vs $199.4M），Ecovyst Inc.同比增速更快（34.0% vs -1.5%），过去两年Ecovyst Inc.的营收复合增速更高（18.7% vs 1.3%）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
ECVT vs TECH — 直观对比
营收规模更大
TECH
是对方的1.6倍
$199.4M
营收增速更快
ECVT
高出35.5%
-1.5%
两年增速更快
ECVT
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $311.4M |
| 净利润 | — | $51.0M |
| 毛利率 | 23.4% | 66.9% |
| 营业利润率 | 10.9% | 24.2% |
| 净利率 | — | 16.4% |
| 营收同比 | 34.0% | -1.5% |
| 净利润同比 | — | 126.0% |
| 每股收益（稀释后） | $0.06 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTTECH
| Q1 26 | — | $311.4M | ||
| Q4 25 | $199.4M | $295.9M | ||
| Q3 25 | $204.9M | — | ||
| Q2 25 | $176.1M | $317.0M | ||
| Q1 25 | $143.1M | $316.2M | ||
| Q4 24 | $148.9M | $297.0M | ||
| Q3 24 | $153.9M | $289.5M | ||
| Q2 24 | $154.0M | $306.1M |
净利润ECVTTECH
| Q1 26 | — | $51.0M | ||
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-79.3M | — | ||
| Q2 25 | $6.0M | $-17.7M | ||
| Q1 25 | $-3.6M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $14.3M | $33.6M | ||
| Q2 24 | $8.3M | $40.6M |
毛利率ECVTTECH
| Q1 26 | — | 66.9% | ||
| Q4 25 | 23.4% | 64.6% | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 22.8% | 62.7% | ||
| Q1 25 | 13.3% | 67.9% | ||
| Q4 24 | 28.9% | 65.3% | ||
| Q3 24 | 29.3% | 63.2% | ||
| Q2 24 | 27.3% | 66.4% |
营业利润率ECVTTECH
| Q1 26 | — | 24.2% | ||
| Q4 25 | 10.9% | 18.4% | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 9.0% | -7.5% | ||
| Q1 25 | -0.7% | 12.2% | ||
| Q4 24 | 15.1% | 16.0% | ||
| Q3 24 | 17.9% | 13.8% | ||
| Q2 24 | 14.1% | 15.0% |
净利率ECVTTECH
| Q1 26 | — | 16.4% | ||
| Q4 25 | — | 12.8% | ||
| Q3 25 | -38.7% | — | ||
| Q2 25 | 3.4% | -5.6% | ||
| Q1 25 | -2.5% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 9.3% | 11.6% | ||
| Q2 24 | 5.4% | 13.3% |
每股收益（稀释后）ECVTTECH
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.06 | $0.24 | ||
| Q3 25 | $-0.69 | — | ||
| Q2 25 | $0.05 | $-0.11 | ||
| Q1 25 | $-0.03 | $0.14 | ||
| Q4 24 | $-0.26 | $0.22 | ||
| Q3 24 | $0.12 | $0.21 | ||
| Q2 24 | $0.07 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $209.8M |
| 总债务越低越好 | $392.6M | — |
| 股东权益账面价值 | $603.4M | $2.1B |
| 总资产 | $1.3B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.65× | — |
8季度趋势，按日历期对齐
现金及短期投资ECVTTECH
| Q1 26 | — | $209.8M | ||
| Q4 25 | $197.2M | $172.9M | ||
| Q3 25 | $82.0M | — | ||
| Q2 25 | $69.6M | $162.2M | ||
| Q1 25 | $127.5M | $140.7M | ||
| Q4 24 | $131.4M | $177.5M | ||
| Q3 24 | $123.5M | $187.5M | ||
| Q2 24 | $83.3M | $152.9M |
总债务ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | $392.6M | $260.0M | ||
| Q3 25 | $854.8M | — | ||
| Q2 25 | $856.6M | $346.0M | ||
| Q1 25 | $859.0M | $330.0M | ||
| Q4 24 | $860.8M | $300.0M | ||
| Q3 24 | $862.7M | $300.0M | ||
| Q2 24 | $862.4M | $319.0M |
股东权益ECVTTECH
| Q1 26 | — | $2.1B | ||
| Q4 25 | $603.4M | $2.0B | ||
| Q3 25 | $607.9M | — | ||
| Q2 25 | $692.4M | $1.9B | ||
| Q1 25 | $698.7M | $2.0B | ||
| Q4 24 | $700.5M | $2.1B | ||
| Q3 24 | $729.4M | $2.1B | ||
| Q2 24 | $717.3M | $2.1B |
总资产ECVTTECH
| Q1 26 | — | $2.6B | ||
| Q4 25 | $1.3B | $2.5B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.8B | $2.6B | ||
| Q4 24 | $1.8B | $2.7B | ||
| Q3 24 | $1.8B | $2.7B | ||
| Q2 24 | $1.8B | $2.7B |
负债/权益比ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | 0.65× | 0.13× | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 1.24× | 0.18× | ||
| Q1 25 | 1.23× | 0.16× | ||
| Q4 24 | 1.23× | 0.14× | ||
| Q3 24 | 1.18× | 0.14× | ||
| Q2 24 | 1.20× | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | — |
| 自由现金流经营现金流 - 资本支出 | $22.9M | — |
| 自由现金流率自由现金流/营收 | 11.5% | — |
| 资本支出强度资本支出/营收 | 9.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $69.9M | — |
8季度趋势，按日历期对齐
经营现金流ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | $41.8M | — | ||
| Q3 25 | $55.3M | — | ||
| Q2 25 | $33.0M | $98.2M | ||
| Q1 25 | $10.3M | $41.1M | ||
| Q4 24 | $43.5M | $84.3M | ||
| Q3 24 | $59.9M | $63.9M | ||
| Q2 24 | $10.0M | $75.5M |
自由现金流ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $53.2M | — | ||
| Q2 25 | $7.8M | $93.3M | ||
| Q1 25 | $-14.0M | $31.0M | ||
| Q4 24 | $30.9M | $77.5M | ||
| Q3 24 | $53.6M | $54.7M | ||
| Q2 24 | $-9.3M | $57.5M |
自由现金流率ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | 11.5% | — | ||
| Q3 25 | 26.0% | — | ||
| Q2 25 | 4.4% | 29.4% | ||
| Q1 25 | -9.8% | 9.8% | ||
| Q4 24 | 20.7% | 26.1% | ||
| Q3 24 | 34.9% | 18.9% | ||
| Q2 24 | -6.1% | 18.8% |
资本支出强度ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | 9.4% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 14.4% | 1.5% | ||
| Q1 25 | 16.9% | 3.2% | ||
| Q4 24 | 8.5% | 2.3% | ||
| Q3 24 | 4.1% | 3.2% | ||
| Q2 24 | 12.5% | 5.9% |
现金转化率ECVTTECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.52× | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 4.21× | 1.90× | ||
| Q2 24 | 1.20× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
